Evidence map›Paper›PMID 32295296›Full record

ReviewInternational journal of molecular sciences2020

Skeletal Dysplasias Caused by Sulfation Defects.

Chiara Paganini, Chiara Gramegna Tota, Andrea Superti-Furga, Antonio Rossi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Chiara PaganiniDepartment of Molecular Medicine, Unit of Biochemistry, University of Pavia, 27100 Pavia, Italy.
Chiara Gramegna TotaDepartment of Molecular Medicine, Unit of Biochemistry, University of Pavia, 27100 Pavia, Italy.
Andrea Superti-FurgaDivision of Genetic Medicine, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.ORCID 0000-0002-3543-7531
Antonio RossiDepartment of Molecular Medicine, Unit of Biochemistry, University of Pavia, 27100 Pavia, Italy.ORCID 0000-0002-2460-8761
University of Pavia · ITUniversity of Lausanne · CH

Funding

FP7 Health 602300Ministero dell'Istruzione, dell'Università e della Ricerca Dipartimenti di Eccellenza 2018-2022Ministero dell'Istruzione, dell'Università e della Ricerca PRIN 2015F3JHMB
6 · The paper itself

Abstract

Proteoglycans (PGs) are macromolecules present on the cell surface and in the extracellular matrix that confer specific mechanical, biochemical, and physical properties to tissues. Sulfate groups present on glycosaminoglycans, linear polysaccharide chains attached to PG core proteins, are fundamental for correct PG functions. Indeed, through the negative charge of sulfate groups, PGs interact with extracellular matrix molecules and bind growth factors regulating tissue structure and cell behavior. The maintenance of correct sulfate metabolism is important in tissue development and function, particularly in cartilage where PGs are fundamental and abundant components of the extracellular matrix. In chondrocytes, the main sulfate source is the extracellular space, then sulfate is taken up and activated in the cytosol to the universal sulfate donor to be used in sulfotransferase reactions. Alteration in each step of sulfate metabolism can affect macromolecular sulfation, leading to the onset of diseases that affect mainly cartilage and bone. This review presents a panoramic view of skeletal dysplasias caused by mutations in genes encoding for transporters or enzymes involved in macromolecular sulfation. Future research in this field will contribute to the understanding of the disease pathogenesis, allowing the development of targeted therapies aimed at alleviating, preventing, or modifying the disease progression.

Indexed as

Disease SusceptibilityProtein Processing, Post-TranslationalAnimalsBone Diseases, DevelopmentalCartilageEnergy MetabolismExtracellular MatrixGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeGlycosaminoglycansHumansMetabolic Networks and PathwaysPhenotypeProteoglycansSulfatesGlycosaminoglycansProteoglycansSulfatescartilagegenotype phenotype correlationglycosaminoglycanproteoglycanskeletal disorderssulfate metabolismsulfotransferase

Identifiers

PMID32295296
PMCPMC7216085
OpenAlexW3017169843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.